Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A halt to neuroblastoma screening in Japan.

Literature DB >> 15128908

A halt to neuroblastoma screening in Japan.

Yoshitaka Tsubono, Shigeru Hisamichi.

Abstract

Entities: Disease

Mesh：

Year: 2004 PMID： 15128908 DOI： 10.1056/NEJM200405063501922

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Conceptualizing overdiagnosis in cancer screening.

Authors: Pamela M Marcus; Philip C Prorok; Anthony B Miller; Emily J DeVoto; Barnett S Kramer
Journal: J Natl Cancer Inst Date: 2015-02-06 Impact factor: 13.506

2. Pediatric robot-assisted laparoscopic radical adrenalectomy and lymph-node dissection for neuroblastoma in a 15-month-old.

Authors: Nabeel I Uwaydah; Alex Jones; Mahmoud Elkaissi; Zhongxin Yu; Blake W Palmer
Journal: J Robot Surg Date: 2013-12-05

3. Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy).

Authors: Elisa Dama; Guido Pastore; Maria Luisa Mosso; Milena Maria Maule; Luisa Zuccolo; Corrado Magnani; Franco Merletti
Journal: Eur J Pediatr Date: 2006-01-13 Impact factor: 3.183

4. Impact of new screening technologies: should we screen and does phenotype influence this decision?

Authors: James Robert Bonham
Journal: J Inherit Metab Dis Date: 2013-03-19 Impact factor: 4.982

Review 5. Reconciling Opportunistic and Population Screening in Clinical Genomics.

Authors: Kyle B Brothers; Jason L Vassy; Robert C Green
Journal: Mayo Clin Proc Date: 2019-01 Impact factor: 7.616

Review 6. The prenatal origins of cancer.

Authors: Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss
Journal: Nat Rev Cancer Date: 2014-03-06 Impact factor: 60.716

A halt to neuroblastoma screening in Japan.

1. Conceptualizing overdiagnosis in cancer screening.

2. Pediatric robot-assisted laparoscopic radical adrenalectomy and lymph-node dissection for neuroblastoma in a 15-month-old.

3. Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy).

4. Impact of new screening technologies: should we screen and does phenotype influence this decision?

Review 5. Reconciling Opportunistic and Population Screening in Clinical Genomics.

Review 6. The prenatal origins of cancer.

7. Infant Cancer in Taiwan: Incidence and Trends (1995-2009).

8. Cancer incidence patterns among children and adolescents in Taiwan from 1995 to 2009: a population-based study.

9. Neuroblastoma Mass Screening--What Can We Learn From It?

10. Secular trends in neuroblastoma mortality before and after the cessation of national mass screening in Japan.